Advance Life-Changing Therapies for Adolescents & Adults With Rare Neurological Disorders
Welcome to the 1st Rare & Genetic Neurodegenerative Drug Development Summit! This trailblazing meeting will be discussing, debating and exploring pivotal rare and genetic neurodegenerative disease research making industry news headlines.
Pioneers in this exclusive industry are joining online, this June, to network and learn from experts in pharma, biotech and academia. The inaugural Rare & Genetic Neurodegenerative Drug Development Summit is hosting enriched, cross-sponsor discussions to re-shape and guide strategic and translational decision-making targeting genetically-defined populations.
With a host of presentations spanning topics from genetic targets to requirements for clinical trial success, this is your opportunity to advance your work and utilize:
2 packed days full of expert-led exclusive content
3 mastermind round table discussions
15+ cutting-edge presentations
Unmissable highlights include but are not limited to:
Revamp your understanding of human genetics and what it teaches us about rare disease
Analyze cross-disease commonalities to overcome heterogeneity within homogenous genetic groups
Refine patient selection of rare patient sub-populations for clinical trial recruitment
Explore biomarkers, digital technologies, and patient-related outcome measures in rare disease populations to shape your clinical decision-making